Safety and antitumor activity of apalutamide (ARN-509) in metastatic castration-resistant prostate cancer with and without prior abiraterone acetate and prednisone

Dana E. Rathkopf, Emmanuel S. Antonarakis, Neal D. Shore, Ronald F. Tutrone, Joshi J. Alumkal, Charles J. Ryan, Mansoor Saleh, Ralph J. Hauke, Rajesh Bandekar, Edna Chow Maneval, Carla J. De Boer, Margaret K. Yu, Howard I. Scher

Research output: Contribution to journalArticlepeer-review

77 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and antitumor activity of apalutamide (ARN-509) in metastatic castration-resistant prostate cancer with and without prior abiraterone acetate and prednisone'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science